Cigna Publishes Lab Management Guidelines V2.0.2026 Effective July 1, 2026 (evicore.com)

• Cigna's updated Lab Management Guidelines V2.0.2026 effective July 1, 2026.
• Covers clinical use guidelines for genetic and lab testing across 861 pages.
• Includes preimplantation genetic testing, liquid biopsy, and multi-cancer early detection screening.
• No explicit metabolomics or AI references in the provided excerpt; inferred relevance to multiomics.
• Document serves as a primary source for payer coverage policies in the US.

"Cigna, through EviCore, has released updated Lab Management Guidelines (V2.0.2026) covering genetic and lab testing policies. The 861-page document includes clinical use guidelines for confirmatory genetic testing, preimplantation genetic testing, and many specific tests. The guidelines take effect July 1, 2026, and apply to Cigna health plans. While no explicit mention of metabolomics or AI is found in the provided excerpt, the document signals payer acceptance of advanced genomic testing in reproductive health."